Münch E, Weigel R, Schmiedek P, Schürer L
Department of Anesthesiology, Klinikum Mannheim, University of Heidelberg, Germany.
Acta Neurochir (Wien). 1998;140(11):1113-9; discussion 1119-20. doi: 10.1007/s007010050224.
Intracranial pressure monitoring has a key role in the management of patients developing increased intracranial pressure (ICP). We adopted the Camino fiberoptic system for intracranial pressure measurement in 1993 in our neurosurgical department. The aim of this study was to investigate reliability, handling characteristics and complication rate of the Camino intracranial pressure device. In an eighteen month period, we prospectively investigated 118 patients with intracranial pathology undergoing Camino fiberoptic intraparenchymal or intraventricular ICP monitoring. The assessment of reliability of ICP monitoring according to patients clinical condition, to cranial computed tomography (CCT) findings and ICP waveform was carried out. Position of the probe and intracranial bleeding complications related to probe insertion were confirmed by CCT. Technical complications, as well as infections due to the device, were documented. In vivo recalibration was performed in 22 patients. At the end of the measuring period the drift of the probe was evaluated and the accuracy of the fiberoptic device was measured by performing a two point calibration. Recordings of intracranial pressure were carried out with 136 Camino devices (104 parenchymal, 32 ventricular) in 118 patients with an average measuring time of 94.1 +/- 79.1 hrs. One hundred and fifteen Camino intracranial pressure devices (85.2%) demonstrated reliability according to the predetermined clinical parameters. The actual mean drift after removal of the devices was 3.4 mmHg +/- 3.2 with an actual daily drift of 3.2 +/- 17.2 mmHg. Recorded complications included infection (0.7%), intraparenchymal haematoma (5.1%), and a high complication rate (23.5%) with regard to technical aspects. The Camino intracranial pressure system offers reliable ICP measurements in an acceptable percentage of devices, and the advantage of in vivo recalibration. The high incidence of technical complications identifies a need for improvement in the fiberoptic cable and the fixation system.
颅内压监测在颅内压(ICP)升高患者的管理中起着关键作用。1993年,我们神经外科采用了卡米诺光纤系统进行颅内压测量。本研究的目的是调查卡米诺颅内压装置的可靠性、操作特性和并发症发生率。在18个月的时间里,我们前瞻性地研究了118例患有颅内病变并接受卡米诺光纤脑实质内或脑室内ICP监测的患者。根据患者的临床状况、头颅计算机断层扫描(CCT)结果和ICP波形对ICP监测的可靠性进行了评估。通过CCT确认探头位置以及与探头插入相关的颅内出血并发症。记录了技术并发症以及该装置导致的感染情况。对22例患者进行了体内重新校准。在测量期结束时,评估探头的漂移情况,并通过两点校准测量光纤装置的准确性。118例患者使用136个卡米诺装置(104个脑实质内的,32个脑室内的)进行颅内压记录,平均测量时间为94.1±79.1小时。根据预定的临床参数,115个卡米诺颅内压装置(85.2%)显示出可靠性。装置移除后的实际平均漂移为3.4 mmHg±3.2,实际每日漂移为3.2±17.2 mmHg。记录的并发症包括感染(0.7%)、脑实质内血肿(5.1%)以及技术方面的高并发症发生率(23.5%)。卡米诺颅内压系统在可接受比例的装置中提供可靠的ICP测量,并且具有体内重新校准的优势。技术并发症的高发生率表明需要改进光纤电缆和固定系统。